← Back to Search

Hydrogel

SWC + Hydrogel for Burns

N/A
Recruiting
Led By Shenda Baker, PhD
Research Sponsored by Synedgen, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 21days
Awards & highlights

Study Summary

This trial tests a wound care product to see how safe and effective it is for burn wounds.

Who is the study for?
This trial is for individuals with good health who have superficial partial-thickness burns covering 5-15% of their body. It's not for those with radiation, chemical or electrical burns, shellfish allergies, pregnant women, or people with severe concurrent diseases. Burns shouldn't be on the face, genitals, across joints or older than 8 days.Check my eligibility
What is being tested?
The study tests SynePure Wound Cleanser combined with Catasyn Hydrogel against SILVADENE Cream to treat superficial partial-thickness burn wounds. The goal is to see which treatment is safer and more effective in healing these types of burns.See study design
What are the potential side effects?
Potential side effects may include allergic reactions to ingredients in the cleanser or hydrogel, skin irritation at the application site, and possible discomfort during use. Specific side effects will be monitored throughout the trial.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 21days
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 21days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Healing wound progress
Secondary outcome measures
New infection rates
Other outcome measures
Complications other than infection

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: SynePure with CatasynExperimental Treatment1 Intervention
SynePure Wound Cleanser and Catasyn Advanced Technology Hydrogel
Group II: SilvadeneActive Control1 Intervention
Routine care wound rinse and Silvadene cream

Find a Location

Who is running the clinical trial?

Louisiana State University Health Sciences Center in New OrleansOTHER
114 Previous Clinical Trials
44,086 Total Patients Enrolled
Synedgen, Inc.Lead Sponsor
2 Previous Clinical Trials
126 Total Patients Enrolled
1 Trials studying Burns
26 Patients Enrolled for Burns
Shenda Baker, PhDPrincipal InvestigatorSynedgen, Inc.
1 Previous Clinical Trials
100 Total Patients Enrolled

Media Library

Catasyn (Hydrogel) Clinical Trial Eligibility Overview. Trial Name: NCT05877638 — N/A
Burns Research Study Groups: SynePure with Catasyn, Silvadene
Burns Clinical Trial 2023: Catasyn Highlights & Side Effects. Trial Name: NCT05877638 — N/A
Catasyn (Hydrogel) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05877638 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are allowed to take part in this research exploration?

"Affirmative. Clinicaltrials.gov attests to the fact that this trial is actively recruiting, having been initially posted on March 27th 2023 and last modified May 17th of the same year. 115 patients are sought from a single site for the study."

Answered by AI

Is this research venture open to new participants at present?

"Affirmative. Details published on clinicaltrials.gov disclose that this examination is currently searching for participants, having been announced March 27th 2023 and last updated May 17th 2023. The study requires 115 individuals to be recruited from 1 centre."

Answered by AI
~55 spots leftby Apr 2025